60 Degrees Pharmaceuticals, Inc.
SXTP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.
Other share classesSXTPW
Holders of 5% or more of SXTP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of 60 Degrees Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Knight Therapeutics Inc. | 13G | 19.85%658.6K shares | +19.85 ppfrom 0.00% | Nov 13, 20243 filings | Jul 29, 2026 | SEC |
| Intracoastal Capital, LLC | 13G/A | 9.99%455.5K shares | 0.00 ppfrom 9.99% | Feb 3, 20254 filings | Nov 7, 2025 | SEC |
| Intracoastal Capital, LLC | 13G/A | 9.99%390.3K shares | +0.89 ppfrom 9.10% | May 13, 20262 filings | Nov 10, 2026 | SEC |
| CVI Investments, Inc. | 13G/A | 7.00%197.9K shares | −2.90 ppfrom 9.90% | Jul 22, 20253 filings | May 15, 2026 | SEC |
| Lind Global Fund III LP | 13G | 5.45%191.6K shares | New | Aug 5, 20261 filing | Aug 5, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on 60 Degrees Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 20265:50 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%390.3K shares | +0.89 ppfrom 9.10% | Sep 30, 2026 | SEC |
| Aug 5, 20265:11 PM ET | Lind Global Fund III LPand 2 others | 13G | 5.45%191.6K shares | New | Jul 31, 2026 | SEC |
| Jul 29, 20264:06 PM ET | Knight Therapeutics Inc. | 13G | 19.85%658.6K shares | +19.85 ppfrom 0.00% | Jul 22, 2026 | SEC |
| May 15, 20264:02 PM ET | Knight Therapeutics Inc. | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2026 | SEC |
| May 15, 202612:21 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 7.00%197.9K shares | −2.90 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 13, 20264:30 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.10%263.2K shares | – | Mar 31, 2026 | SEC |
| Nov 13, 20253:49 PM ET | Ayrton Capital LLCand 2 others | 13G/A | 4.14%177.4K shares | −5.85 ppfrom 9.99%Below 5% | Sep 30, 2025 | SEC |
| Nov 7, 20255:30 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%455.5K shares | 0.00 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Nov 7, 20254:54 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 9.90%455.5K shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Jul 22, 20259:59 AM ET | CVI Investments, Inc.and 1 other | 13G | 9.90%328.1K shares | New | Jul 15, 2025 | SEC |
| Jul 18, 20255:46 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 9.99%372.4K shares | +5.00 ppfrom 4.99% | Jul 15, 2025 | SEC |
| Jul 17, 20254:59 PM ET | Orca Capital AG | 13G/A | 4.90%166.2K shares | −5.00 ppfrom 9.90%Below 5% | Jul 15, 2025 | SEC |
| Jul 17, 20254:57 PM ET | Orca Capital AG | 13G | 9.90%320.0K shares | New | Jul 15, 2025 | SEC |
| May 15, 20253:10 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%77.4K shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| May 14, 20252:57 PM ET | Ayrton Capital LLCand 2 others | 13G | 9.99%163.5K shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20255:21 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%476.9K shares | – | Dec 31, 2024 | SEC |
| Feb 11, 20254:53 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%386.8K shares | 0.00 ppfrom 4.99%Below 5% | Feb 5, 2025 | SEC |
| Feb 3, 20254:05 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%284.6K shares | NewBelow 5% | Jan 28, 2025 | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Nov 13, 2024 | Knight Therapeutics Inc | 13G/AOld format | – | – | – | SEC |
| May 7, 2024 | Knight Therapeutics International SA | 13G/AOld format | – | – | – | SEC |
| Dec 18, 2023 | Knight Therapeutics International SA | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell 60 Degrees Pharmaceuticals, Inc. shares.
No Form 144 notices for 60 Degrees Pharmaceuticals, Inc. are on file.